Bio-Rad Laboratories Class BBIO.B
13F holders, Q1 2024 (March 31)7holders
$342.28avg. 13F price*
At the end of Q1 2024, 7 institutions reported holding Bio-Rad Laboratories Class B (BIO.B) in their 13F filings. The largest holders were CSS LLC ($625K), Buckingham Strategic Wealth, LLC ($259K) and Morgan Stanley ($247K).
- Company
- Bio-Rad Laboratories Class B
- CUSIP
- 090572108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $11K |
| Exits | 0 | $0 |
Ownership 7 holders
| CSS LLC | 0.15% | Reduce -0.2% | 1,807 | $625K |
| Buckingham Strategic Wealth, LLC | 0.00% | No change | 760 | $259K |
| Morgan Stanley | 0.00% | No change | 724 | $247K |
| Wells Fargo & Company | 0.00% | No change | 170 | $56K |
| Whittier Trust Co. | 0.00% | No change | 160 | $52K |
| Jones Financial Companies LLLP | 0.00% | New | 33 | $11K |
| JNBA Financial Advisors | 0.00% | No change | 2 | $682 |
"% of holder's portfolio" is BIO.B's weight in each manager's 13F, not the share of Bio-Rad Laboratories Class B the manager owns.